| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |